PRF Technologies Ltd. (PRFX) vs Silexion Therapeutics Ltd. (SLXN)
A side-by-side comparison of PRF Technologies Ltd. and Silexion Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PRFX
PRF Technologies Ltd.
$0.89HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
SLXN
Silexion Therapeutics Ltd.
$0.26HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
Total return — PRFX vs SLXN
growth of $100 · dividends reinvested · last 2yPRFX -90.3% (-68.8%/yr)SLXN -100.0% (-99.0%/yr)PRFX compounded faster over this window
Log scale — wide-divergence pair
PRFX SLXN
PRFX vs SLXN: by the numbers
- •SLXN is the larger company ($109735 vs $71488 market cap).
- •Both run net losses; SLXN's is the smaller (0.00% vs -22521.52% net margin).
Metrics side by side
Valuation
| Metric | PRFX | SLXN |
|---|---|---|
| P/S ratio | 1.81 | N/A |
| P/B ratio | 0.00 | 2.49 |
Profitability
| Metric | PRFX | SLXN |
|---|---|---|
| Gross margin | -4864.71% | 0.00% |
| Operating margin | -29335.29% | 0.00% |
| Net margin | -22521.52% | 0.00% |
| ROE | -56.04% | -31722.73% |
| ROIC | -53.95% | N/A |
Growth (annualized)
| Metric | PRFX | SLXN |
|---|---|---|
| Total return CAGR (5Y) | -74.50% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.